Oseltamivir is protective for in-patient mortality in PCR confirmed influenza B and influenza A(H3N2) infections in an historic cohort of 1,048 patients hospitalised during the 2016-17 and 2017-18 influenza seasons.
Reacher M, Warne B, Verlander NQ, Popay A, Reeve L, Jones NK, Ranellou K, Sithole N, Carpenter R, Everden A, Jarman E, Khalid A, Lam K, Myers C, Ren S, Rolfe KJ, Sutton T, Christou S, Wright C, Choudhry S, Zambon M, Sander C, Zhang H, Jalal H.
Reacher M, et al. Among authors: lam k.
J Infect. 2023 Mar;86(3):256-308. doi: 10.1016/j.jinf.2023.01.004. Epub 2023 Jan 14.
J Infect. 2023.
PMID: 36646142